Atlas Trials

Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial

Clinical trial NCT05738681 · UNKNOWN

Trial details

NCT number
NCT05738681
Sponsor
Mahidol University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
TuberculosisDrug Induced Liver InjuryHepatitis
Start date
2022-09-09
Primary completion
2023-03-31
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.